RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 91.70
+10.50 (12.93%)
Jan 7, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 48.82 billion as of January 7, 2026. Its market cap has increased by 197.37% in one year.
Market Cap
48.82B
Enterprise Value
49.91B
Revenue
2.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
91.70
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 48.82B, an increase of 46.20%. That is a compound annual growth rate of 7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 48.82B | 8.00% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 268.19B |
| Hansoh Pharmaceutical Group Company | 220.61B |
| JD Health International | 180.84B |
| Innovent Biologics | 135.60B |
| WuXi Biologics | 134.33B |
| Sino Biopharmaceutical | 113.70B |
| Akeso | 104.37B |
| CSPC Pharmaceutical Group | 96.95B |